Compare CNNE & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNNE | YDES |
|---|---|---|
| Founded | 2014 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Restaurants | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 609.0M | 543.0M |
| IPO Year | 2017 | N/A |
| Metric | CNNE | YDES |
|---|---|---|
| Price | $13.71 | $2.59 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $20.25 | N/A |
| AVG Volume (30 Days) | ★ 377.7K | 17.8K |
| Earning Date | 05-11-2026 | 05-12-2026 |
| Dividend Yield | ★ 4.47% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $499,700,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.37 | N/A |
| 52 Week Low | $10.46 | $2.38 |
| 52 Week High | $21.96 | $25.00 |
| Indicator | CNNE | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 43.02 | 26.93 |
| Support Level | $12.59 | N/A |
| Resistance Level | $15.03 | $5.36 |
| Average True Range (ATR) | 0.52 | 0.40 |
| MACD | -0.13 | -0.01 |
| Stochastic Oscillator | 11.11 | 2.74 |
Cannae Holdings Inc is an investment holding company that acquires and actively manages equity interests in operating businesses across various industries. The Company focuses on long-term ownership and seeks to create value by supporting the growth and operations of its portfolio companies through management expertise and strategic oversight. The Company operates through four reportable segments: Restaurant Group, which includes the operations of O'Charleys and 99 Restaurants; Alight, which represents its ownership interest in a technology-enabled human capital and employee benefits solutions provider; Black Knight Football Club (BKFC), which holds interests in professional football clubs; and JANA, which represents its investment in an investment management firm.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.